The Role of microRNA-210 in the Pathogenesis and Diagnosis of Preeclampsia—A Systematic Review
Open Access
- 26 October 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7593
Abstract
Background: Preeclampsia is a complex hypertensive disorder of pregnancy associated with significant maternal and foetal morbidity and mortality. Its pathogenesis involves placental hypoxia, oxidative stress, and impaired trophoblast invasion. Recent evidence highlights the role of microRNAs, particularly microRNA-210 (miR-210), in the molecular disruptions underlying preeclampsia. Aim: This study aims to explore the pathogenic, diagnostic, and therapeutic significance of miR-210 in preeclampsia, with emphasis on its molecular mechanisms, biomarker potential, and prospects as a therapeutic target. Methods: A systematic narrative review was conducted following PRISMA guidelines. A total of 498,184 articles were identified through eight scientific databases, and, after duplicate removal and eligibility screening, 111 peer-reviewed studies published between 2015 and 2025 were included in the final analysis. The selected literature focused on miR-210’s expression in placental tissue and maternal circulation, its molecular targets, and its clinical relevance. Results: miR-210 is consistently upregulated in preeclamptic placentas and maternal plasma. It contributes to shallow trophoblast invasion, impaired angiogenesis, mitochondrial dysfunction, and the activation of a hypoxia-induced HIF-1α feedback loop. These mechanisms are central to the disease’s pathophysiology. Clinically, miR-210 demonstrates high stability in circulation and early detectability, making it a promising diagnostic and prognostic biomarker. Experimental models have also demonstrated the therapeutic potential of miR-210 inhibition using antisense oligonucleotides or HIF-1α modulators. Conclusions: miR-210 is both a marker and mediator of preeclampsia. Its integration into diagnostic protocols and therapeutic strategies, alongside clinical validation and standardisation, may enhance early detection and personalised care in high-risk pregnancies.Keywords
This publication has 112 references indexed in Scilit:
- Redefining pre‐eclampsia as Type I or II: implementing an integrated model of the maternal‐cardiovascular–placental–fetal arrayUltrasound in Obstetrics & Gynecology, 2023
- Preeclampsia and the Kidney: Pathophysiology and Clinical ImplicationsComprehensive Physiology, 2023
- MicroRNAs: key regulators of the trophoblast function in pregnancy disordersJournal of Assisted Reproduction and Genetics, 2022
- Recent insights into the microRNA and long non-coding RNA-mediated regulation of stem cell populations3 Biotech, 2022
- Secretome of Stem Cells: Roles of Extracellular Vesicles in Diseases, Stemness, Differentiation, and ReprogrammingTissue Engineering and Regenerative Medicine, 2021
- The role of endoglin and its soluble form in pathogenesis of preeclampsiaMolecular and Cellular Biochemistry, 2021
- DICER: structure, function, and regulationBiophysical Reviews, 2021
- Diagnostic mesothelioma biomarkers in effusion cytologyCancer Cytopathology, 2021
- MicroRNAs: Small molecules with a large impact on pre‐eclampsiaJournal of Cellular Physiology, 2019
- Expression patterns of placental microRNAsBirth Defects Research Part A: Clinical and Molecular Teratology, 2011